Everett E. Vokes to Dyspnea
This is a "connection" page, showing publications Everett E. Vokes has written about Dyspnea.
Connection Strength
0.037
-
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1104-1115.
Score: 0.037